ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,942Medicare Part D Prescriptions Filled, Including Refills

Rank: 49 out of 917

$671K Total Retail Price of All Prescriptions

Rank: 50 out of 917

365 Patients Receiving at Least One Drug in Part D
93%Patients 65 Years and Older
34% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Washington
Lower avg

Schedule Two
Controlled Substances

9% of this provider’s 365 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

20% of this provider’s 365 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Risky Drugs to Seniors

1% of this provider’s 11,145 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$56 was the average price of a prescription from this provider, compared to $56 among peers.

Prescriptions per Patient

33 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Washington
AMLODIPINE BESYLATE 515 503 1 5
LEVOTHYROXINE SODIUM 394 357 2 3
OMEPRAZOLE 374 369 3 4
LISINOPRIL 371 364 4 1
CITALOPRAM HBR 330 318 5 15
METFORMIN HCL 319 299 6 8
LOSARTAN POTASSIUM 279 269 7 13
SIMVASTATIN 275 267 8 2
LOVASTATIN 266 234 9 19
FUROSEMIDE 263 256 10 7
GABAPENTIN 262 254 11 17
DONEPEZIL HCL 233 233 12 32
HYDROCODONE-ACETAMINOPHEN 174 154 S3 13 6
NAMENDA 167 167 14 43
SPIRIVA 167 142 14 45
HYDROCHLOROTHIAZIDE 143 134 16 9
METOPROLOL SUCCINATE 142 135 17 18
TRAZODONE HCL 141 137 18 22
ATORVASTATIN CALCIUM 135 131 19 14
FINASTERIDE 130 108 20 77
ATENOLOL 121 107 21 12
FLUTICASONE PROPIONATE 117 88 22 26
ALLOPURINOL 117 117 22 31
TRAMADOL HCL 113 110 24 28
ZOLPIDEM TARTRATE 113 88 24 21
WARFARIN SODIUM 113 113 24 10
PREDNISONE 109 105 27 34
METOPROLOL TARTRATE 95 95 28 11
PRAVASTATIN SODIUM 92 76 29 20
SERTRALINE HCL 92 87 29 24
ALENDRONATE SODIUM 91 89 31 23
JANUVIA 87 81 32 81
TAMSULOSIN HCL 84 71 33 25
PANTOPRAZOLE SODIUM 83 78 34 44
VENLAFAXINE HCL ER 79 76 35 78
POTASSIUM CHLORIDE 76 76 36 16
ROPINIROLE HCL 73 70 37 88
CARVEDILOL 71 66 38 33
KLOR-CON 10 70 70 39 115
MIRTAZAPINE 69 69 40 39
FENOFIBRATE 67 66 41 73
ACETAMINOPHEN-CODEINE 64 63 S3 42 109
FLOVENT HFA 64 63 42 192
OXYCODONE HCL 63 59 S2 44 27
MELOXICAM 63 53 44 53
NEXIUM 61 61 46 60
DIOVAN 60 55 47 49
SYMBICORT 60 39 47 206
CLOPIDOGREL 60 60 47 50
VESICARE 58 55 50 166
RISPERIDONE 58 52 50 51
CRESTOR 56 47 52 30
LOSARTAN-HYDROCHLOROTHIAZIDE 55 55 53 62
SYNTHROID 55 53 53 68
CHOLESTYRAMINE 53 49 55 379
OXYBUTYNIN CHLORIDE 53 50 55 76
LACTULOSE 50 50 57 133
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on April 24, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.